SensDx
SensDx is a company dedicated to revolutionizing medical diagnosis by providing effective, rapid, and easy-to-use tests for detecting pathogens causing specific diseases. Their mission is to prevent the spreading of bacteria and viruses by early detection of pathogens. They develop ultra-sensitive diagnostic platforms and tests, including for influenza viruses, with applications across human and veterinary medicine, cardiology, oncology, urology, and more. Their innovative technology combines ultrasensitive microsensors with a mobile application for digital analysis and monitoring.
Industries
Nr. of Employees
small (1-50)
Patents
Sensor for the impedance measurements of the biological or chemical factor sample and the method for the detection of the biological or chemical factor in the sample using such a sensor
US-12066395-B2
View Details
Sensor for the impedance measurements of the biological or chemical factor sample and the method for the detection of the biological or chemical factor in the sample using such a sensor
US-12066395-B2
View DetailsProducts
Mobi SensDx Reader
A compact reader device that interfaces with ultrasensitive disposable microsensor tests and a mobile app for reading and interpreting assay results.
Flu SensDx Assay
A rapid assay for detecting influenza viruses designed for early-stage detection with claimed sensitivity comparable to RT-PCR and a result time measured in minutes.
Veti SensDx Assay (under development)
Assay development targeting livestock diseases including equine and avian influenza for veterinary applications.
Intimate SensDx Assay (under development)
Assay in development to identify causes of intimate (genitourinary) infections.
Uro SensDx Assay (under development)
Assay in development for diseases of the digestive and urinary tract.
Strepto SensDx Assay (under development)
Assay under development to detect Streptococcus species.
Mobi SensDx Reader
A compact reader device that interfaces with ultrasensitive disposable microsensor tests and a mobile app for reading and interpreting assay results.
Flu SensDx Assay
A rapid assay for detecting influenza viruses designed for early-stage detection with claimed sensitivity comparable to RT-PCR and a result time measured in minutes.
Veti SensDx Assay (under development)
Assay development targeting livestock diseases including equine and avian influenza for veterinary applications.
Intimate SensDx Assay (under development)
Assay in development to identify causes of intimate (genitourinary) infections.
Uro SensDx Assay (under development)
Assay in development for diseases of the digestive and urinary tract.
Strepto SensDx Assay (under development)
Assay under development to detect Streptococcus species.
Services
Establishment of distribution agreements and collaboration with partners for international sales and market entry; contact provided for distribution inquiries.
Direct regional sales presence and contact points for Central and Eastern Europe (Poland, Czech Republic, Slovakia, Hungary).
Establishment of distribution agreements and collaboration with partners for international sales and market entry; contact provided for distribution inquiries.
Direct regional sales presence and contact points for Central and Eastern Europe (Poland, Czech Republic, Slovakia, Hungary).
Expertise Areas
- Point-of-care diagnostics
- Electrochemical sensor functionalization
- Assay development for infectious and molecular markers
- Mobile digital health and result reporting
Key Technologies
- Electrochemical microsensors
- Bioreceptor-functionalized electrodes
- Mobile diagnostic applications
- Multiplex/multisensor assay platforms
News & Updates
We are awarded and honored in the Innovative Company category during the Final of the 13th edition of the Innovator Mazowsza competition for FluSensor SensDx – developing a solution for detecting the influenza virus at an early stage of infection!
We are pleased to announce that from today it will be possible to use Flu SensDx at home!
SensDx received the Good Design 2020 New Technologies award for Flu SensDx – a mobile diagnostic platform for pathogen detection!
SensDx Digital Diagnostics presented at Roche Innovation Summit in Basel and won the Future Diagnostics category among 150 companies.
We are awarded and honored in the Innovative Company category during the Final of the 13th edition of the Innovator Mazowsza competition for FluSensor SensDx – developing a solution for detecting the influenza virus at an early stage of infection!
We are pleased to announce that from today it will be possible to use Flu SensDx at home!
SensDx received the Good Design 2020 New Technologies award for Flu SensDx – a mobile diagnostic platform for pathogen detection!
SensDx Digital Diagnostics presented at Roche Innovation Summit in Basel and won the Future Diagnostics category among 150 companies.